Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease

Journal of Nuclear Medicine

Volumn 37, Issue 11, 1996, Pages 1749-1755

  Van Dyck, Christopher H ^a   Lin, C Huie ^a   Smith, Eileen O ^a   Wisniewski, Gary ^a   Cellar, Janet ^a   Robinson, Rhonda ^a   Narayan, Meena ^a   Bennett, Alexandre ^a   Delaney, Richard C ^a   Bronen, Richard A ^a   Hoffer, Paul B ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; SPECT; technetium 99m ECD; technetium 99m HMPAO

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; BRAIN; CYSTEINE; FEMALE; HUMANS; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; OXIMES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 10344232669     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Johnson KA, Mueller ST, Walshe TM, English RJ, Holman BL. Cerebral perfusion imaging in Alzheimer's disease. Arch Neurol 1987;44:165-168.
2. Jagust WJ, Budinger TF, Reed BR. The diagnosis of dementia with single-photon emission computed tomography. Arch Neurol 1987;44:258-262.
3. Holman BL, Johnson KA, Gerada B, Carvalho PA, Satlin A. The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT. J Nucl Med 1992;33:181-185.
4. Johnson KA, Kijewski MF, Becker JA, Garada B, Satlin A, Holman BL. Quantitative brain SPECT in Alzheimer's disease and normal aging. J Nucl Med 1993;34:2044-2048.
5. Bonte FJ, Tintner R, Weiner MF, Bigio EH, White III CL. Brain blood flow in the dementias: SPECT with histopathologic correlation. Radiology 1993;186:361-365.
6. 99mTc-HMPAO SPECT and temporal lobe oriented x-ray CT scans [Abstract]. J Nucl Med 1994; 35(suppl):20P.
7. Jobst KA, Hindley NJ, King E, Smith AD. The diagnosis of Alzheimer's disease: a question of image? J Clin Psychiatry 1994;55:22-31.
8. Neirinckx RD, Canning LR, Piper IM, et al. Technetium-99md,1-HM-PAO: A new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. J Nucl Med 1987;28:191-202.
9. Sharp PF, Smith FW, Gemmell HG, et al. Technetium-99m-HMPAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies. J Nucl Med 1986;27:171-177.
10. Walovitch RC, Hill TC, Garrity ST, et al. Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, part 1: pharmacology of technetium-99m-ECD in nonhuman primates. J Nucl Med 1989;30:1892-1901.
11. Léveillé J, Demonceau G, De Roo M, et al. Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, part 2: biodistribution and brain imaging in humans. J Nucl Med 1989;30:1902-1910.
12. Vallabhajosula S, Zimmerman RE, Picard M, et al. Technetium-99m-ECD: a new brain imaging agent: in vivo kinetics and biodistribution studies in normal human subjects. J Nucl Med 1989;30:599-604.
13. 99mTc-HMPAO compared to xenon-133. J Cereb Blood Flow Metab 1988;8:S69-S81.
14. 99mTc]-d,1-hexamethyl-propylene amine oxime (HMPAO) compared with regional cerevral blood flow measured by PET: effects of linearization. J Cereb Blood Flow Metab 1988;8:S82-S89.
15. Devous MDS, Payne JK, Lowe JK, Leroy RF. Comparison of technetium-99m-ECD to xenon-133 SPECT in normal controls and in patients with mild to moderate regional cerebral blood flow abnormalities. J Nucl Med 1993;34:754-761.
16. 99mTc] ethyl cysteinate dimer in nonhuman primates. Stroke 1990;21: 1059-1063.
17. Léveillé J, Demonceau G, Walovitch RC. Intrasubject comparison between technelium-99m-ECD and technetium-99m-HMPAO in healthy human subjects. J Nucl Med 1992;33:480-484.
18. 99mTc-HMPAO. Clin Nucl Med 1993;18:754-758.
19. Tsuchida T, Nishizawa S, Yonekura Y, et al. SPECT Images of technetium-99m-ethyl cysteinate dimer in cerebrovascular diseases: comparison with other cerebral perfusion tracers and PET. J Nucl Med. 1994;35:27-31.
20. 123I-IMP: preliminary results [Abstract]. Eur J Nucl Med 1988;14:311.
21. 99mTc-HMPAO. In: Hartmann A, Hoyer S, Kuschinky W, eds. Cerebral ischemia and dementia. Stuttgart: Springer-Verlag; 1991:327-333.
22. 99mTc-ECD: measurement of arterial input and brain retention. Eur J Nucl Med 1994;21:124-130.
23. 99mTc-HMPAO with dynamic brain SPECT and compartment model [Abstract]. J Nucl Med 1992;33(suppl):969.
24. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
25. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psych 1960;23:56-62.
26. Hachinski VC, Iliff LD, Zilhka E, et al. Cerebral blood flow in dementia. Arch Neurol 1975;32:632-637.
27. Folstein MF, Fostein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
28. Mattis S. Mental status examination for organic mental syndrome in the elderly patient. In: Bellack L, Karasu TB, eds. Geriatric psychiatry. New York: Grune & Stratton; 1976:77-121.
29. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984;141:1356-1364.
30. Wechsler D. Wechsler adult intelligence scale - revised. New York: Psychological Corporation; 1981.
31. 99mTc-biscisate (ECD, Neurolite) measured by SPECT on same day. J Cereb Blood Flow Metab 1994;14:S44-S48.
32. 99mTc-biscisate: comparison with PET measurement and linearization based on permeablility-surface area product model. J Cereb Blood Flow Metab 1994;14:S58-S65.
33. 99mTc-bicisate in activation studies by split-dose technique. J Cereb Blood Flow Metab 1994;14:S115-S120.
34. Genna S, Smith AP. The development of ASPECT, an annular single crystal brain camera for high efficiency SPECT. IEEE Trans Nucl Sci 1988;NS-35:654-658.
35. Holman BL, Carvalho PA, Zimmerman RE, et al. Brain perfusion SPECT using an annular single crystal camera: initial clinical experience. J Nucl Med 1990;31:1456-1461.
36. Kumar A, Schapiro MB, Grady C, et al. High-resolution PET studies in Alzheimer's disease. Neuropsychopharmacology 1991;4:35-46.
37. Matsui T, Hirano A. An atlas of the human brain for computerized tomography. Tokyo: Igaku-Shoin, Ltd; 1978.
38. Brun A, Englund E. Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading. Histopathology 1981;5:549-564.
39. Pearson RCA, Esiri MM, Hiorns RW, Wilcock GK, Powell TPS. Anatomical correlated of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc Natl Acad Sci 1985;82:4531-4534.
40. Rogers J, Morrison JH. Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease. J Neurosci 1985;5:2801-2808.
41. Fukuyama H, Ogawa M, Yamauchi H, et al. Altered cerebral energy metabolism in Alzheimer's disease: a PET study. J Nucl Med 1994;35:1-6.
42. Kushner M, Tobin M, Alavi A, et al. Cerebellar glucose consumption in normal and pathologic states using fluorine-18-FDG and PET. J Nucl Med 1987;28:1667-1670.
43. Herholz K, Perani D, Salmon E, et al. Comparability of FDG-PET studies in probable Alzheimer's disease. J Nucl Med 1993;34:1460-1466.
44. Herholz K, Adams R, Szelies B, Grond M, Heiss W-D. Criteria for the diagnosis of Alzheimer's disease with positron emission tomography. Dementia 1990;1:156-164.
45. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-843.
46. Morris J, McKeel D, Fulling K, Torack R, Berg L. Validation of clinical diagnostic criteria for Alzheimer's disease. Ann Neurol 1988;24:17-22.
47. Budinger TF, Derenzo SE, Greenberg WL, Guilberg GT. Quantitative potentials of dynamic emission computed tomography. J Nucl Med 1978;19:309-315.
48. Di Rocco RJ, Silva DA, Kuczynski BL, et al. The single-pass cerebral extraction and capillary permeability-surface area product of several putative cerebral blood flow imaging agents. J Nucl Med 1993;34:641-648.
49. 99mTc-HMPAO [Abstract]. J Nucl Med 1992;33(suppl):909.
50. 99mTc-ECD in the human brain using compartment model analysis and dynamic SPECT [Abstract]. J Nucl Med 1991;32(suppl):911.
51. 123I]IMP in cortical and subcortical strokes. J Cereb Blood Flow Metab 1994;14:S84-S90.